Anyone with current or recent cancer should approach BPC-157 with extreme caution and qualified medical guidance
modified insulin-like growth factor-1, TB-500, hematide/peginesatide, growth hormone releasing peptides, AOD-9604, etc.) and non-peptidic (selective androgen receptor modulators, hypoxia-inducible factor stabilizers, siRNA, S-107 and ARM036/aladorian, etc.) as well as inorganic (cobalt) nature are considered and discussed in terms of specific requirements originating from physicochemical properties, concentration levels, metabolism, and their amenability for chromatographic-mass spectrometric or alternative detection methods
doi:10.1007/s00403-009-0942-x
If cells become resistant to insulin, the blood glucose is stored as fat instead of used for energy, which causes weight gain instead of weight loss
Comprehensive reviews describe BPC-157 within the broader framework of cytoprotection in the gastrointestinal tract and beyond (Sikiric 2019, review)